Extend Biosciences Begins Human Testing of EXT608

The Company is excited to announce that recruiting is ongoing for healthy volunteers to participate in Extend Biosciences’ Phase 1 trial of EXT608. The trial is being funded in-part by NIDDK.

->View the clinical trials.gov entry here